How to Apply Basic Science at the Bedside
"You have a full warehouse of knowledge.
The problem is — you don't know how to place a clinical address label on it."
Understand the structure or process in its healthy state. This is the baseline — without it, you cannot recognise deviation.
Trace the pathological mechanism. What breaks down, what accumulates, what is lost. This is pathophysiology — the mechanism of disease.
Connect the mechanism to the sign or symptom you will see, hear, or elicit at the bedside. This is the clinical output of the science.
Structure and spatial relationships translate to examination findings, nerve injury patterns, surgical landmarks, and procedural sites.
Normal processes translate to the mechanisms of compensation, decompensation, and symptom generation when those processes are disrupted.
Mechanism of action translates to side effect prediction, drug selection rationale, interaction awareness, and dose calculation logic.
Metabolic pathways and tissue changes translate to understanding what investigations measure, why results are abnormal, and what they mean.
Every pre-clinical subject you studied has something to say about this child. The table below shows the same three questions applied across all four domains — in one reading.
| Domain | The Science — Normal | The Pathology — When Disrupted | Clinical Recognition — In This Child |
|---|---|---|---|
| Anatomy | Meninges enclose the subarachnoid space containing CSF. Spinal cord ends at L1–L2. Anterior fontanelle open until ~18 months. | Bacterial infection inflames the meninges and subarachnoid space. Inflammatory exudate irritates nerve roots passing through the space. Exudate obstructs CSF flow, raising ICP. |
Neck stiffness — meningeal irritation, not
muscle spasm
Kernig's sign — inflamed lumbar roots resist
stretch
LP at L3–L4 — safely below the cord
|
| Physiology | Blood-brain barrier (BBB) tight junctions exclude pathogens and large molecules. Monroe-Kellie: fixed intracranial volume — any volume increase raises ICP. | Bacterial toxins disrupt BBB tight junctions → leukocytes and proteins enter CSF → cytokine cascade → cerebral oedema → ICP rises → cerebral perfusion falls. |
Bulging fontanelle — open fontanelle
transmits raised ICP
Projectile vomiting — ICP stimulates vomiting
centre
Altered consciousness — falling cerebral
perfusion; late sign
|
| Pharmacology | Beta-lactams inhibit cell wall synthesis. Intact BBB excludes most antibiotics from the CNS. Corticosteroids suppress the inflammatory cytokine cascade. | Inflamed BBB becomes paradoxically permeable — cephalosporins now cross in therapeutic concentrations. Dexamethasone before antibiotics blunts the lysis-triggered inflammatory surge. |
Ceftriaxone — crosses inflamed meninges;
covers this age group
Dexamethasone first — reduces oedema and
hearing loss risk
Weight-based dosing — pharmacokinetics differ
in children
|
| Biochemistry | Normal CSF: protein 0.15–0.45 g/L, glucose ~60–70% of serum, fewer than 5 WBC/mm³ (lymphocytes). Neutrophils recruited in acute pyogenic infection. | Protein rises as BBB breaks down — plasma proteins leak in. Glucose falls — bacteria and activated leukocytes consume it faster than replenishment. Neutrophilia — acute pyogenic response. |
CSF protein ↑ — BBB breakdown; correlates
with severity
CSF glucose ↓ — compare to simultaneous
serum; ratio <0.5 significant
Neutrophils ↑ — bacterial until proven
otherwise
|
Which organ, structure, pathway, or drug is involved? Name it precisely — not "the kidney" but "the proximal tubular reabsorption of glucose."
Normal function
→ pathology when disrupted
→ clinical
recognition.
Run through all three before you stop. Do not
skip to the clinical without the mechanism.
Every mechanism produces an observable output — a symptom, a sign, or an investigation result. Find that output. That is where the science meets the patient.